Holen Sie sich die Stockscreener-App
0.7181
1.93%
-0.0141
Schlusskurs vom Vortag:
$0.7322
Offen:
$0.73
24-Stunden-Volumen:
505.84K
Relative Volume:
0.67
Marktkapitalisierung:
$37.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.22M
KGV:
-0.2426
EPS:
-2.96
Netto-Cashflow:
$-74.41M
1W Leistung:
+1.71%
1M Leistung:
-10.77%
6M Leistung:
+2.59%
1J Leistung:
-32.57%
1-Tages-Spanne:
$0.7109
$0.732
1-Wochen-Bereich:
$0.68
$0.7494
52-Wochen-Spanne:
$0.615
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
Firmenname
Xilio Therapeutics Inc
Sektor
Branche
Telefon
617-833-1027
Adresse
828 WINTER STREET, WALTHAM
Vergleichen Sie XLO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.7181 | 38.44M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | Leerink Partners | Outperform |
| 2022-12-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-16 | Eingeleitet | Cowen | Outperform |
| 2021-11-16 | Eingeleitet | Guggenheim | Buy |
| 2021-11-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-11-16 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Xilio Therapeutics Inc Aktie (XLO) Neueste Nachrichten
Xilio Therapeutics Inc (XLO) can make a big difference with a little luck - Setenews
Is Xilio Therapeutics Inc. stock trading at a premium valuationJuly 2025 Sentiment & Fast Gain Swing Alerts - Newser
Why Xilio Therapeutics Inc. stock is trending among retail traders2025 Price Action Summary & Expert Curated Trade Ideas - Newser
Can Xilio Therapeutics Stock Recover If Markets Fall? - Trefis
Recap Report: Why Xilio Therapeutics Inc. stock attracts high net worth investorsProduct Launch & High Accuracy Investment Signals - moha.gov.vn
Xilio Therapeutics Approves 2025 Stock Incentive Plan - MSN
[S-8] Xilio Therapeutics, Inc. Employee Benefit Plan Registration | XLO SEC FilingForm S-8 - Stock Titan
[Form 4] Xilio Therapeutics, Inc. Insider Trading Activity - Stock Titan
[8-K] Xilio Therapeutics, Inc. Reports Material Event | XLO SEC FilingForm 8-K - Stock Titan
AbbVie and Xilio partner for tumor-activated therapies - MSN
Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates - MSN
Is Xilio Therapeutics Inc. stock a buy before product launchesJuly 2025 Rallies & Low Drawdown Momentum Ideas - newser.com
How institutional buying supports Xilio Therapeutics Inc. stockMarket Performance Report & High Accuracy Trade Alerts - newser.com
Is Xilio Therapeutics Inc. stock resilient to inflationWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com
Is Xilio Therapeutics Inc a good long term investmentFundamental Stock Analysis & Free Technical Analysis and Insights - earlytimes.in
Can Samtex Fashions Limited Outperform Index Funds Over the Next 5 YearsEmerging Market Stocks & Free Rapid Profit Acceleration - earlytimes.in
Can GSM Foils Limited Sustain EPS Growth Under Competitive PressureEquity Performance Review & Low Risk Trading Portfolio - earlytimes.in
Is ACRS a good long-term investment? - earlytimes.in
Tick level data insight on Xilio Therapeutics Inc. volatilityGlobal Markets & Stock Timing and Entry Methods - newser.com
How Xilio Therapeutics Inc. stock compares to market leadersWeekly Gains Report & High Accuracy Trade Signal Alerts - newser.com
Why Xilio Therapeutics Inc. stock remains on watchlists2025 Buyback Activity & Fast Gain Swing Alerts - newser.com
Xilio Therapeutics Reports Revenue Growth Amidst Challenges - MSN
Why Xilio Therapeutics Inc. stock is in analyst buy zoneTrade Exit Summary & Verified Entry Point Signals - newser.com
How geopolitical tensions affect Xilio Therapeutics Inc. stock2025 Macro Impact & Daily Stock Momentum Reports - newser.com
Is Xilio Therapeutics Inc. stock safe for conservative investorsJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Is it too late to sell Xilio Therapeutics Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Is it time to cut losses on Xilio Therapeutics Inc.Portfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Published on: 2025-11-19 00:08:23 - newser.com
Building trade automation scripts for Xilio Therapeutics Inc.July 2025 Review & Risk Controlled Stock Alerts - newser.com
Tools to assess Xilio Therapeutics Inc.’s risk profileInsider Selling & Real-Time Stock Movement Alerts - newser.com
What drives WHLRD stock priceDouble Top/Bottom Patterns & Low Risk Trading Plans - earlytimes.in
Top Growth Drivers Behind Omnitex Industries India Limited Stocks Recent SurgeRisk Mitigation Techniques & Affordable Market Insights - earlytimes.in
What makes Xilio Therapeutics Inc. stock attractive to growth fundsFed Meeting & Risk Managed Investment Entry Signals - newser.com
What machine learning models say about Xilio Therapeutics Inc.July 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Published on: 2025-11-15 13:28:14 - newser.com
Best data tools to analyze Xilio Therapeutics Inc. stockBreakout Watch & Weekly Chart Analysis and Guides - newser.com
Finanzdaten der Xilio Therapeutics Inc-Aktie (XLO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):